Drug Development Research

Quinalizarin induces cycle arrest and apoptosis via reactive oxygen species-mediated signaling pathways in human melanoma A375 cells

Berberine inhibits the interleukin-1 beta-induced inflammatory response via MAPK downregulation in rat articular chondrocytes

Reaching toward underexplored targets in antibacterial drug design

Synergistic interaction between docosahexaenoic acid and diclofenac on inflammation, nociception, and gastric security models in rats

Synthesis, anticonvulsant screening, and molecular modeling studies of new arylalkylimidazole oxime ether derivatives

Design and synthesis of simplified speciophylline analogues and beta-carbolines as active molecules against Plasmodium falciparum

Antiviral compound screening, peptide designing, and protein network construction of influenza a virus (strain a/Puerto Rico/8/1934 H1N1)

An updated overview with simple and practical approach for developing in vitro-in vivo correlation

Pharmacological interaction of -bisabolol and diclofenac on nociception, inflammation, and gastric integrity in rats

Drug development and bioanalytical method validation for a novel anticancer molecule, 4-(dimethylamino)-2-(p-tolylamino) thiazole-5-carbonitrile